Please use this identifier to cite or link to this item:
https://observatorio.fm.usp.br/handle/OPI/34839
Title: | Association of KRAS mutational status with response to pembrolizumab monotherapy given as first-line therapy for PD-L1-positive advanced non-squamous NSCLC in KEYNOTE-042 |
Authors: | HERBST, R. S.; LOPES, G.; KOWALSKI, D. M.; KASAHARA, K.; WU, Y-L.; CASTRO JR., G. De; CHO, B. C.; TURNA, H. Z.; CRISTESCU, R.; AURORA-GARG, D.; LUNCEFORD, J.; KOBIE, J.; AYERS, M.; PIETANZA, M. C.; PIPERDI, B.; MOK, T. S. K. |
Citation: | ANNALS OF ONCOLOGY, v.30, suppl.11, 2019 |
Appears in Collections: | Comunicações em Eventos - FM/MDR Comunicações em Eventos - HC/ICESP Comunicações em Eventos - LIM/24 |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.